Thought on several problems of clinical revaluation of post-marketing herb research.
- Author:
Wei HE
1
;
Yanming XIE
;
Yongyan WANG
Author Information
1. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700.
- Publication Type:Journal Article
- MeSH:
China;
Drug Therapy;
Drug-Related Side Effects and Adverse Reactions;
Drugs, Chinese Herbal;
adverse effects;
standards;
Humans;
Product Surveillance, Postmarketing
- From:
China Journal of Chinese Materia Medica
2010;35(12):1641-1643
- CountryChina
- Language:Chinese
-
Abstract:
The revaluation of post-marketing herb is a complex research work, which concerns widely content and difficult to put it into practice. The starting of our country's revaluation post-marketing herb was comparatively late. It should profect it both in laws and regulations mechanism as well as technological specification. This article is try to focus on some attention problems in revaluation of postmarketing herb process. Such as the laws and regulations demand, the basement and the subject of revaluation of post-marketing herb.
